PEGylated Protein Therapeutics Market, Global Outlook and Forecast 2022-2028

April 2022 | 63 pages | ID: PCC73C618C75EN
Market Monitor Global

Abstracts

PEGylation is the process of covalent and non-covalent attachment of polyethylene glycol polymer chains to molecules, such as a drug, therapeutic protein, or vesicle. PEGylated protein therapeutics is estimated to show significant market growth during the forecast period, majorly due to the, growth in demand for PEGylation, rise in number of chronic diseases, and presence of strong pipeline drugs.

This report contains market size and forecasts of PEGylated Protein Therapeutics in Global, including the following market information:

Global PEGylated Protein Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global PEGylated Protein Therapeutics market was valued at 10010 million in 2021 and is projected to reach US$ 12950 million by 2028, at a CAGR of 3.7% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Colony Stimulating Factor Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of PEGylated Protein Therapeutics include Merck, Pfizer, UCB, Amgen, AstraZeneca, Biogen, Roche, Horizon Pharma and Leadiant Biosciences. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the PEGylated Protein Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global PEGylated Protein Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global PEGylated Protein Therapeutics Market Segment Percentages, by Type, 2021 (%)

• Colony Stimulating Factor
• Interferon
• Erythropoietin (EPO)
• Recombinant Factor VIII
• Monoclonal Antibody
• Enzyme
• Others

Global PEGylated Protein Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global PEGylated Protein Therapeutics Market Segment Percentages, by Application, 2021 (%)

• Cancer
• Autoimmune Disease
• Hepatitis
• Multiple Sclerosis
• Hemophilia
• Gastrointestinal Disorder
• Others

Global PEGylated Protein Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global PEGylated Protein Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies PEGylated Protein Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies PEGylated Protein Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Merck
• Pfizer
• UCB
• Amgen
• AstraZeneca
• Biogen
• Roche
• Horizon Pharma
• Leadiant Biosciences

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 PEGylated Protein Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global PEGylated Protein Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL PEGYLATED PROTEIN THERAPEUTICS OVERALL MARKET SIZE

2.1 Global PEGylated Protein Therapeutics Market Size: 2021 VS 2028
2.2 Global PEGylated Protein Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top PEGylated Protein Therapeutics Players in Global Market
3.2 Top Global PEGylated Protein Therapeutics Companies Ranked by Revenue
3.3 Global PEGylated Protein Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 PEGylated Protein Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies PEGylated Protein Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 PEGylated Protein Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 PEGylated Protein Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 PEGylated Protein Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global PEGylated Protein Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 Colony Stimulating Factor
  4.1.3 Interferon
  4.1.4 Erythropoietin (EPO)
  4.1.5 Recombinant Factor VIII
  4.1.6 Monoclonal Antibody
  4.1.7 Enzyme
  4.1.8 Others
4.2 By Type - Global PEGylated Protein Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global PEGylated Protein Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global PEGylated Protein Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global PEGylated Protein Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global PEGylated Protein Therapeutics Market Size, 2021 & 2028
  5.1.2 Cancer
  5.1.3 Autoimmune Disease
  5.1.4 Hepatitis
  5.1.5 Multiple Sclerosis
  5.1.6 Hemophilia
  5.1.7 Gastrointestinal Disorder
  5.1.8 Others
5.2 By Application - Global PEGylated Protein Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global PEGylated Protein Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global PEGylated Protein Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global PEGylated Protein Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global PEGylated Protein Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global PEGylated Protein Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global PEGylated Protein Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global PEGylated Protein Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global PEGylated Protein Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America PEGylated Protein Therapeutics Revenue, 2017-2028
  6.3.2 US PEGylated Protein Therapeutics Market Size, 2017-2028
  6.3.3 Canada PEGylated Protein Therapeutics Market Size, 2017-2028
  6.3.4 Mexico PEGylated Protein Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe PEGylated Protein Therapeutics Revenue, 2017-2028
  6.4.2 Germany PEGylated Protein Therapeutics Market Size, 2017-2028
  6.4.3 France PEGylated Protein Therapeutics Market Size, 2017-2028
  6.4.4 U.K. PEGylated Protein Therapeutics Market Size, 2017-2028
  6.4.5 Italy PEGylated Protein Therapeutics Market Size, 2017-2028
  6.4.6 Russia PEGylated Protein Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries PEGylated Protein Therapeutics Market Size, 2017-2028
  6.4.8 Benelux PEGylated Protein Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia PEGylated Protein Therapeutics Revenue, 2017-2028
  6.5.2 China PEGylated Protein Therapeutics Market Size, 2017-2028
  6.5.3 Japan PEGylated Protein Therapeutics Market Size, 2017-2028
  6.5.4 South Korea PEGylated Protein Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia PEGylated Protein Therapeutics Market Size, 2017-2028
  6.5.6 India PEGylated Protein Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America PEGylated Protein Therapeutics Revenue, 2017-2028
  6.6.2 Brazil PEGylated Protein Therapeutics Market Size, 2017-2028
  6.6.3 Argentina PEGylated Protein Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa PEGylated Protein Therapeutics Revenue, 2017-2028
  6.7.2 Turkey PEGylated Protein Therapeutics Market Size, 2017-2028
  6.7.3 Israel PEGylated Protein Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia PEGylated Protein Therapeutics Market Size, 2017-2028
  6.7.5 UAE PEGylated Protein Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Merck
  7.1.1 Merck Corporate Summary
  7.1.2 Merck Business Overview
  7.1.3 Merck PEGylated Protein Therapeutics Major Product Offerings
  7.1.4 Merck PEGylated Protein Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 Merck Key News
7.2 Pfizer
  7.2.1 Pfizer Corporate Summary
  7.2.2 Pfizer Business Overview
  7.2.3 Pfizer PEGylated Protein Therapeutics Major Product Offerings
  7.2.4 Pfizer PEGylated Protein Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 Pfizer Key News
7.3 UCB
  7.3.1 UCB Corporate Summary
  7.3.2 UCB Business Overview
  7.3.3 UCB PEGylated Protein Therapeutics Major Product Offerings
  7.3.4 UCB PEGylated Protein Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 UCB Key News
7.4 Amgen
  7.4.1 Amgen Corporate Summary
  7.4.2 Amgen Business Overview
  7.4.3 Amgen PEGylated Protein Therapeutics Major Product Offerings
  7.4.4 Amgen PEGylated Protein Therapeutics Revenue in Global Market (2017-2022)
  7.4.5 Amgen Key News
7.5 AstraZeneca
  7.5.1 AstraZeneca Corporate Summary
  7.5.2 AstraZeneca Business Overview
  7.5.3 AstraZeneca PEGylated Protein Therapeutics Major Product Offerings
  7.5.4 AstraZeneca PEGylated Protein Therapeutics Revenue in Global Market (2017-2022)
  7.5.5 AstraZeneca Key News
7.6 Biogen
  7.6.1 Biogen Corporate Summary
  7.6.2 Biogen Business Overview
  7.6.3 Biogen PEGylated Protein Therapeutics Major Product Offerings
  7.6.4 Biogen PEGylated Protein Therapeutics Revenue in Global Market (2017-2022)
  7.6.5 Biogen Key News
7.7 Roche
  7.7.1 Roche Corporate Summary
  7.7.2 Roche Business Overview
  7.7.3 Roche PEGylated Protein Therapeutics Major Product Offerings
  7.7.4 Roche PEGylated Protein Therapeutics Revenue in Global Market (2017-2022)
  7.7.5 Roche Key News
7.8 Horizon Pharma
  7.8.1 Horizon Pharma Corporate Summary
  7.8.2 Horizon Pharma Business Overview
  7.8.3 Horizon Pharma PEGylated Protein Therapeutics Major Product Offerings
  7.8.4 Horizon Pharma PEGylated Protein Therapeutics Revenue in Global Market (2017-2022)
  7.8.5 Horizon Pharma Key News
7.9 Leadiant Biosciences
  7.9.1 Leadiant Biosciences Corporate Summary
  7.9.2 Leadiant Biosciences Business Overview
  7.9.3 Leadiant Biosciences PEGylated Protein Therapeutics Major Product Offerings
  7.9.4 Leadiant Biosciences PEGylated Protein Therapeutics Revenue in Global Market (2017-2022)
  7.9.5 Leadiant Biosciences Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. PEGylated Protein Therapeutics Market Opportunities & Trends in Global Market
Table 2. PEGylated Protein Therapeutics Market Drivers in Global Market
Table 3. PEGylated Protein Therapeutics Market Restraints in Global Market
Table 4. Key Players of PEGylated Protein Therapeutics in Global Market
Table 5. Top PEGylated Protein Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global PEGylated Protein Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global PEGylated Protein Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies PEGylated Protein Therapeutics Product Type
Table 9. List of Global Tier 1 PEGylated Protein Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 PEGylated Protein Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global PEGylated Protein Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - PEGylated Protein Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - PEGylated Protein Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global PEGylated Protein Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - PEGylated Protein Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - PEGylated Protein Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global PEGylated Protein Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global PEGylated Protein Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global PEGylated Protein Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America PEGylated Protein Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America PEGylated Protein Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe PEGylated Protein Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe PEGylated Protein Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia PEGylated Protein Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia PEGylated Protein Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America PEGylated Protein Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America PEGylated Protein Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa PEGylated Protein Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa PEGylated Protein Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Merck Corporate Summary
Table 31. Merck PEGylated Protein Therapeutics Product Offerings
Table 32. Merck PEGylated Protein Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Pfizer Corporate Summary
Table 34. Pfizer PEGylated Protein Therapeutics Product Offerings
Table 35. Pfizer PEGylated Protein Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. UCB Corporate Summary
Table 37. UCB PEGylated Protein Therapeutics Product Offerings
Table 38. UCB PEGylated Protein Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Amgen Corporate Summary
Table 40. Amgen PEGylated Protein Therapeutics Product Offerings
Table 41. Amgen PEGylated Protein Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. AstraZeneca Corporate Summary
Table 43. AstraZeneca PEGylated Protein Therapeutics Product Offerings
Table 44. AstraZeneca PEGylated Protein Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. Biogen Corporate Summary
Table 46. Biogen PEGylated Protein Therapeutics Product Offerings
Table 47. Biogen PEGylated Protein Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Roche Corporate Summary
Table 49. Roche PEGylated Protein Therapeutics Product Offerings
Table 50. Roche PEGylated Protein Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. Horizon Pharma Corporate Summary
Table 52. Horizon Pharma PEGylated Protein Therapeutics Product Offerings
Table 53. Horizon Pharma PEGylated Protein Therapeutics Revenue (US$, Mn), (2017-2022)
Table 54. Leadiant Biosciences Corporate Summary
Table 55. Leadiant Biosciences PEGylated Protein Therapeutics Product Offerings
Table 56. Leadiant Biosciences PEGylated Protein Therapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. PEGylated Protein Therapeutics Segment by Type in 2021
Figure 2. PEGylated Protein Therapeutics Segment by Application in 2021
Figure 3. Global PEGylated Protein Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global PEGylated Protein Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global PEGylated Protein Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by PEGylated Protein Therapeutics Revenue in 2021
Figure 8. By Type - Global PEGylated Protein Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global PEGylated Protein Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global PEGylated Protein Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America PEGylated Protein Therapeutics Revenue Market Share, 2017-2028
Figure 12. US PEGylated Protein Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada PEGylated Protein Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico PEGylated Protein Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe PEGylated Protein Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany PEGylated Protein Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France PEGylated Protein Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. PEGylated Protein Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy PEGylated Protein Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia PEGylated Protein Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries PEGylated Protein Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux PEGylated Protein Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia PEGylated Protein Therapeutics Revenue Market Share, 2017-2028
Figure 24. China PEGylated Protein Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan PEGylated Protein Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea PEGylated Protein Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia PEGylated Protein Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India PEGylated Protein Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America PEGylated Protein Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil PEGylated Protein Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina PEGylated Protein Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa PEGylated Protein Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey PEGylated Protein Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel PEGylated Protein Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia PEGylated Protein Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE PEGylated Protein Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Merck PEGylated Protein Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Pfizer PEGylated Protein Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. UCB PEGylated Protein Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Amgen PEGylated Protein Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. AstraZeneca PEGylated Protein Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Biogen PEGylated Protein Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Roche PEGylated Protein Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Horizon Pharma PEGylated Protein Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Leadiant Biosciences PEGylated Protein Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)